The Potential of AI in Analyzing Medical Data and Ensuring Privacy

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter explores the use of AI in analyzing medical data and generating fictional data for research, addressing concerns about privacy and participation. The hosts express optimism while discussing upcoming topics including Reid's decision on an open letter about AI's existential risk and his collaboration with Microsoft.

Are AI’s harshest critics causing irreversible harm to humanity? How far should leaders lean into AI? And just what would Reid sound like speaking Chinese with a British accent?

Reid Hoffman sits down with CEO of WaitWhat and longtime friend Jeff Berman to tackle these pressing questions and more. Join them in an unguarded exploration of how the AI landscape has continued to shift in the six months since Reid published Impromptu, the book he co-authored with ChatGPT.

Reid also gives a sneak peek into his work with Microsoft's unreleased AI text-to-speech tech, and discusses why he chose not to join Elon Musk, Steve Wozniak and other tech leaders in signing an open letter warning about the existential threat of AI.

Plus, you’ll hear how early stage business leaders should tap their network to take advantage of AI, and how larger organizations should create long-term strategic plans that can adapt at the drop of a hat.

Read a transcript of this episode: https://mastersofscale.com/

Subscribe to the Masters of Scale weekly newsletter: https://mastersofscale.com/subscribe

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.